Delivery Order SPE2DB22D2206-SPE2DB24FGS34
Award Date 4/16/24
Potential Completion Date 5/7/24
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, with a ceiling value of $19,999.44, is for the provision of the pharmaceutical product PADCEV 30 MG VIALS to the Defense Logistics Agency (DLA). The contract is a Delivery Order issued under the company's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical...
- This federal contract award, valued at $14,999.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product PADCEV 30 MG VIALS and has a completion date of June 11, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, is delivering these items without any set-aside designation. This contract is associated with a...
- This federal contract award, valued at $116,823.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of PADCEV 30 MG VIALS, and has an ultimate completion date of January 9, 2024. The contract is a firm fixed-price arrangement, and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award, valued at $5,172.68, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is for the product "PADCEV 30 MG VIALS" and has an ultimate completion date of January 17, 2025. The contract was not designated with a set-aside requirement,...
- This federal contract award, valued at $18,479.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PADCEV 20 MG VIALS, a pharmaceutical product, with a completion date of March 25, 2025. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $29,211.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 mg vials of Padcev, an oncology pharmaceutical. The award, issued on December 8, 2025, with completion targeted for December 30, 2025, represents a competitively awarded, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $37,975.20 to AmerisourceBergen Drug Corp for the supply of Padcev 30 mg vials, a specialized pharmaceutical product. The contract, issued on December 2, 2025, with an ultimate completion date of December 23, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was made by the Defense Logistics Agency (DLA) on June 25, 2024. The $41,647.50 firm fixed-price delivery order is for the supply of PADCEV 30 MG vials, with a completion date of July 17, 2024. The contract is not designated as a set-aside. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
- This federal contract award, valued at $22,175.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PADCEV 30 MG VIALS, a pharmaceutical product, with a completion date of February 25, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a Set-Aside contract. AmerisourceBergen Drug Corp holds a significant...
- The Defense Logistics Agency awarded a delivery order valued at $53.5K to AmerisourceBergen Drug Corp for supply of Padcev 30 mg vials, a specialty pharmaceutical product. This non-set-aside, competitively awarded contract carries firm fixed pricing and is scheduled for completion by February 5, 2026. The award was issued on January 14, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGS34Delivery Order
This federal contract award is for the supply of Padcev 30 mg vials by Amerisourcebergen Drug Corp's Corporate Office Division to the Defense Logistics Agency (DLA). The $24,999.30 firm fixed price delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain network to efficiently fulfill this and other federal government contracts for critical medical products.
Generated 7/16/24, 1:07 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.0k | 4/16/24 |